HOSPITAL-SERVICE UTILIZATION BY HIV AIDS PATIENTS AND THEIR MANAGEMENT COST IN A PROVINCIAL GENITOURINARY MEDICINE DEPARTMENT

Citation
A. Nageswaran et al., HOSPITAL-SERVICE UTILIZATION BY HIV AIDS PATIENTS AND THEIR MANAGEMENT COST IN A PROVINCIAL GENITOURINARY MEDICINE DEPARTMENT, International journal of STD & AIDS, 6(5), 1995, pp. 336-344
Citations number
NO
Categorie Soggetti
Immunology,"Infectious Diseases
ISSN journal
09564624
Volume
6
Issue
5
Year of publication
1995
Pages
336 - 344
Database
ISI
SICI code
0956-4624(1995)6:5<336:HUBHAP>2.0.ZU;2-7
Abstract
The hospital management of 108 HIV/AIDS patients cared for by the geni tourinary medicine department, Sheffield, UK between 1984-93 was retro spectively studied to quantify the services utilized by these patients and to detail the management costs (1993 price) of outpatient (OF) se rvices, inpatient (IP) care, investigational services and therapeutic provisions. The services utilized and cost are presented separately fo r the different clinical stages of the infection and as per patient ye ar. Of the 108 patients, 95 (88%) were males and 13 (12%) females; mos t males (76.8%) acquired the infection through homosexual exposure, wh ile 46% of females acquired it heterosexually. The mean number of OP c onsultation per asymptomatic, symptomatic non-AIDS and AIDS patient ye ars were 11.6, 16.4 and 32.8 respectively; the mean number of IP episo des for each of these clinical groups were 0.15, 0.83 and 3.88 with IP stays 0.7, 3.5 and 40.6 days per patient year respectively. The annua l costs of OP care ($45.26 per consultation), drugs and investigations were, respectively $525, $213 and $153 per asymptomatic patient year, $742, $2097 and $224 per symptomatic non AIDS patient year and $1485, $2928 and $382 per AIDS patient year. The average annual OP drug cost per patient year showed little change since 1988. However, in the AID S group, contributions from differing drug classes showed significant changes; while the contribution of antiretroviral drugs fell from 80.2 % of the drug cost per AIDS patient year in 1990 to 31.3% in 1993, tha t from antibiotics rose from 0.3% in 1990 to 26.4% in 1993 and other a ntivirals from 9.4% in 1988 to 22.6% in 1993. These changes were relat ed to lower recommended daily dosage of zidovudine and to wider prescr iption of antibiotics for atypical mycobacterial infections and domici liary gancyclovir for CMV infection. The costs of annual mean IP care, IP drugs, IP investigations and IP procedures per AIDS patient year w ere $5926 ($146 per IP stay), $2983, $282 and $145 respectively. The o verall management cost of one AIDS patient year was $14 131 and lifeti me AIDS management cost, based on a mean survival of 17 months, a Litt le more than $20 000. The annual management cost of an asymptomatic an d symptomatic non-AIDS patient year is approximately 1/14th and 1/4th of the cost of an AIDS patient year.